68 related articles for article (PubMed ID: 19591554)
1. Nuchal translucency and lymphatic system maldevelopment.
Bellini C; Rutigliani M; Boccardo FM; Bonioli E; Campisi C; Grillo F; Bellini T; Valenzano M; Fulcheri E
J Perinat Med; 2009; 37(6):673-6. PubMed ID: 19591554
[TBL] [Abstract][Full Text] [Related]
2. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema.
Bekker MN; van den Akker NM; de Mooij YM; Bartelings MM; van Vugt JM; Gittenberger-de Groot AC
Reprod Sci; 2008 Apr; 15(3):295-304. PubMed ID: 18421024
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Shh and FOXC2 expression correlates with aberrant lymphatic development in human fetuses with increased nuchal translucency.
de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; Wisse LJ; van Vugt JM; Gittenberger-de Groot AC
Prenat Diagn; 2009 Sep; 29(9):840-6. PubMed ID: 19548265
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical studies in a hydroptic fetus with pulmonary lymphangiectasia and trisomy 21.
Rutigliani M; Boccardo F; Campisi C; Bonioli E; Fulcheri E; Bellini C
Lymphology; 2007 Sep; 40(3):114-21. PubMed ID: 18062612
[TBL] [Abstract][Full Text] [Related]
5. Aberrant lymphatic development in euploid fetuses with increased nuchal translucency including Noonan syndrome.
de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; van Vugt JM; Gittenberger-de Groot AC
Prenat Diagn; 2011 Feb; 31(2):159-66. PubMed ID: 21268034
[TBL] [Abstract][Full Text] [Related]
6. Nuchal edema and venous-lymphatic phenotype disturbance in human fetuses and mouse embryos with aneuploidy.
Bekker MN; van den Akker NM; Bartelings MM; Arkesteijn JB; Fischer SG; Polman JA; Haak MC; Webb S; Poelmann RE; van Vugt JM; Gittenberger-de Groot AC
J Soc Gynecol Investig; 2006 Apr; 13(3):209-16. PubMed ID: 16638592
[TBL] [Abstract][Full Text] [Related]
7. Lymphangioma and congenital pulmonary lymphangiectasis: a histologic, immunohistochemical, and clinicopathologic comparison.
Brown M; Pysher T; Coffin CM
Mod Pathol; 1999 Jun; 12(6):569-75. PubMed ID: 10392631
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls.
von Kaisenberg CS; Wilting J; Dörk T; Nicolaides KH; Meinhold-Heerlein I; Hillemanns P; Brand-Saberi B
Mol Hum Reprod; 2010 Oct; 16(10):778-89. PubMed ID: 20457798
[TBL] [Abstract][Full Text] [Related]
9. Cardiac defects, nuchal edema and abnormal lymphatic development are not associated with morphological changes in the ductus venosus.
Burger NB; Haak MC; Kok E; de Groot CJ; Shou W; Scambler PJ; Lee Y; Cho E; Christoffels VM; Bekker MN
Early Hum Dev; 2016 Oct; 101():39-48. PubMed ID: 27405055
[TBL] [Abstract][Full Text] [Related]
10. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
[TBL] [Abstract][Full Text] [Related]
11. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
12. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
Bronshtein M; Zimmer EZ; Blazer S
Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
[TBL] [Abstract][Full Text] [Related]
13. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
14. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas.
Franke FE; Steger K; Marks A; Kutzner H; Mentzel T
J Cutan Pathol; 2004 May; 31(5):362-7. PubMed ID: 15059220
[TBL] [Abstract][Full Text] [Related]
15. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
[TBL] [Abstract][Full Text] [Related]
16. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre.
Clur SA; Mathijssen IB; Pajkrt E; Cook A; Laurini RN; Ottenkamp J; Bilardo CM
Prenat Diagn; 2008 Apr; 28(4):347-54. PubMed ID: 18382996
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of increased fetal nuchal translucency thickness.
Chen CP
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):133-8. PubMed ID: 20708516
[TBL] [Abstract][Full Text] [Related]
18. Nuchal translucency measurement in normal fetuses.
Pajkrt E; Bilardo CM; Van Lith JM; Mol BW; Bleker OP
Obstet Gynecol; 1995 Dec; 86(6):994-7. PubMed ID: 7501355
[TBL] [Abstract][Full Text] [Related]
19. Evaluating nuchal translucency scans performed for trisomy screening in a district general hospital between July 1998 and January 2004.
MacRae R; Ojutiku D; Duke-MacRae J; Usifo F; Ekong M
J Obstet Gynaecol; 2008 Oct; 28(7):683-7. PubMed ID: 19065360
[TBL] [Abstract][Full Text] [Related]
20. The clinical evaluation and pregnancy outcome of euploid fetuses with increased nuchal translucency.
Maymon R; Herman A
Clin Genet; 2004 Nov; 66(5):426-36. PubMed ID: 15479188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
